Brief: Pharmasimple 2020 Sales Up At 45.2 Million Euros
Feb 25 (Reuters) - PHARMASIMPLE SA ALPHS.PA :
* 2020 SALES GREW BY 61% (AFTER + 67% IN 2019) TO REACH EUR
45.2
MILLION
* CONFIRMATION OF POSITIVE EBITDA IN 2020
* IN 2021, GROUP INTENDS TO PURSUE IMPLEMENTATION OF
STRATEGIC
PLAN AIMED AT INCREASING ITS MARKET SHARE
Source text for Eikon: ID:nACT68047
Further company coverage: ALPHS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months